本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Rhythm Pharmaceuticals Inc.

104.71
+2.512.46%
盤後104.710.00000.00%19:30 EDT
成交量:57.37萬
成交額:6,014.22萬
市值:72.10億
市盈率:-33.59
高:106.57
開:102.96
低:102.25
收:102.20
52周最高:122.20
52周最低:74.50
股本:6,885.21萬
流通股本:6,539.41萬
量比:1.33
換手率:0.88%
股息:- -
股息率:- -
每股收益(TTM):-3.1172
每股收益(LYR):-3.1100
淨資產收益率:-117.04%
總資產收益率:-30.96%
市淨率:70.01
市盈率(LYR):-33.67

資料載入中...

2024/08/06

重要事件披露

Form 8-K - Current report
2024/07/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

重要事件披露

Form 8-K - Current report
2024/06/17

重要事件披露

Form 8-K - Current report
2024/05/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/30

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/17

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/16

重要事件披露

Form 8-K - Current report
2024/04/03

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/20

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report